Woo Raymond sold $119K of CBLL
Woo Raymond (Chief Technology Officer) sold 4,887 shares of Ceribell, Inc. (CBLL) at $24.38 ($0.12M total) on 2026-10-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The sale is small and unlikely to move the stock significantly; investors may monitor for larger future disposals.
Market read
A low‑impact insider sale with limited trading relevance.
What to watch
Potential upcoming corporate actions or financing needs could later make insider sales more meaningful, but none are indicated here.
Background
SEC Form 4 filing discloses an insider transaction by Ceribell's CTO, a routine 10b5‑1 sale.
Ticker impact
CTO Woo Raymond sold 4,887 shares of Ceribell for $119,145, reducing his stake to 203,118 shares via a 10b5‑1 plan.
likely modest pressure as the market prices in the insider sell
The transaction size ($119k) is small relative to market cap and represents a routine 10b5‑1 sale, so any impact will be limited.
Market effects
Minimal; the sale does not signal broader trends in the medical‑device sector.
None; the filing is company‑specific.
None
Counterpoint
If the insider had a larger stake or sold a significant portion, the market might view it as a negative signal, but the modest size suggests no material concern.
Key entities
- companyCeribell, Inc.
Medical‑device company developing rapid diagnostic platforms.
- personWoo Raymond
Chief Technology Officer of Ceribell, filing insider sale.